Itraconazole: Its possible role in inhibiting angiogenesis in Rheumatoid Arthritis

Medical Hypotheses

Volumn 79, Issue 3, 2012, Pages 313-314

  Sheikh, Asfandyar ^a   Naqvi, Syed Hassan Abbas ^a,c   Naqvi, Syed Hassan Shiraz ^a,c   Sheikh, Kainat ^b,c  

^a DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^b DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^c NONE   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; GOLD SALT; HLA DR1 ANTIGEN; HYDROXYCHLOROQUINE; INFLIXIMAB; INTERLEUKIN 1; ITRACONAZOLE; LEFLUNOMIDE; METHOTREXATE; PENICILLAMINE; PLACEBO; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; NONHUMAN; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SERUM; SYMPTOM; SYNOVIAL FLUID; SYNOVITIS; TREATMENT DURATION; TREATMENT INDICATION;

EID: 84864593110     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.05.019     Document Type: Article

References (18)

1. Roschmann R.A., Rothenberg R.J. Pulmonary fibrosis in rheumatoid arthritis: a review of clinical features and therapy. Semin Arthritis Rheum 1987, 16(3):174-185.
2. Gerli R., Goodson N.J. Cardiovascular involvement in rheumatoid arthritis. Lupus 2005, 14:679-682.
3. Lee A.N., Beck C.E., Hall M. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review. Clin Lab Sci 2008, 21(1):15-18.
4. Mackenzie A.H. Differential diagnosis of rheumatoid arthritis. Am J Med 1988, 85(4A):2-11.
5. Van Gestel A.M., Prevoo M.L., van't Hof M.A., van Rijswijk M.H., van de Putte L.B., van Riel P.L. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996, 39:34-40.
6. Feldmann M., Brennan F.M., Foxwell B.M., Maini R.N. The role of TNF alpha and IL-1 in rheumatoid arthritis. Curr Dir Autoimmun 2001, 3:188-199.
7. Mahdi H., Fisher B.A., Kallberg H., et al. Specific interaction between genotype smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat Genet 2009, 41:1319-1324.
8. Saag K.G., Teng G.G., Patkar N.M., et al. American College of Rheumatology recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Care Res 2008, 59:762-784.
9. Szekanecz Z., Pakozdi A., Szentpetery A., Besenyei T., Koch A.E. Chemokines and angiogenesis in rheumatoid arthritis. Front Biosci 2009, 1:44-51.
10. McInnes I.B., Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011, 365:2205-2219.
11. Lee S.S., Joo Y.S., Kim W.U., et al. Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 2001, 19(3):321-324.
12. Pinheiro G.R., Andrade C.A., Gayer C.R., Coelho M.S., Freire S.M., Scheinberg M.A. Serum vascular endothelial growth factor in late rheumatoid arthritis. Clin Exp Rheumatol 2001, 19(6):721-723.
13. Taylor P.C. VEGF and imaging of vessels in rheumatoid arthritis. Arthritis Res 2002, 4(3):99-107.
14. Chong C.R., Xu J., Lu J., Bhat S., Sullivan D.J., Liu J.O. Inhibition of angiogenesis by the antifungal drug itraconazole. ACS Chem Biol 2007, 2:263-270.
15. Xu J., Dang Y., Ren Y.R., Liu J.O. Cholesterol trafficking is required for mTOR activation in endothelial cells. Proc Natl Acad Sci USA 2001, 107(10):4764-4769.
16. Kim J., Tang J.Y., Gong R., et al. Itraconazole, a commonly used antifungal drug that inhibits Hedgehog pathway activity and cancer growth. Cancer Cell 2010, 17(4):388-399.
17. Nacev B.A., Grassi P., Dell A., Haslam S.M., Liu J.O. The antifungal drug itraconazole inhibits vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation trafficking and signaling in endothelial cells. J Biol Chem 2011, 286(51):44045-44056.
18. Aftab B.T., Dobromilskaya I., Liu J.O., Rudin C.M. Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer. Cancer Res 2011, 71(21):6764-6772.